ArticleJAMA2018
Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.
Article in JAMA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed.
- Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.The Journal of urology · 2023Trial
- Article
- Life expectancy estimation in older men using the prostate cancer comorbidity index in VA & SEER-Medicare cohorts.Age and ageing · 2026Observational
- Physician Preferences Regarding Integration of Life Expectancy in Prostate Cancer Management.Journal of general internal medicine · 2026Article
- Genomics in active surveillance and post-prostatectomy patients: A review of when and how to use effectively.Current urology reports · 2024Review
- Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis.Annals of internal medicine · 2024Article
- Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era.Urologic oncology · 2024Article
- Location and Types of Treatment for Prostate Cancer After the Veterans Choice Program Implementation.JAMA network open · 2023Article
- Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.The Journal of urology · 2023Article
- Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer.Cancer medicine · 2023Article
- Prostate cancer grade migration and facility-level treatment trends for grade group 1 disease.JNCI cancer spectrum · 2023Article
- Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US.JAMA network open · 2023Article
- A vision for closing the evidence-practice gap in the management of low-grade prostate cancer.JNCI cancer spectrum · 2023Article
- Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer.Cancer medicine · 2023Article
- Large variation in conservative management of low-risk prostate cancer in Australia and New Zealand.BJU international · 2022Article
- Article
- Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance.Journal of the National Comprehensive Cancer Network : JNCCN · 2022Article
- Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.HGG advances · 2022Article
- The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis.Journal of the National Cancer Institute · 2021Article
- Economic Evaluation of Urine-Based or Magnetic Resonance Imaging Reflex Tests in Men With Intermediate Prostate-Specific Antigen Levels in the United States.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.